We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Tagore College of Pharmacy, Rathinamangalam, Chennai, Tamilnadu, India.
This research sought to improve the solubility and therapeutic effectiveness of Glibenclamide, an anti-diabetic medication with poor water solubility, by creating a nanosuspension formulation that included Bougainvillea spectabilis extract. Glibenclamide, classified as a BCS Class II drug, has limited aqueous solubility, which consequently restricts its dissolution rate and oral bioavailability. The inclusion of Bougainvillea spectabilis, a medicinal plant known for its D-pinitol content and demonstrated anti-diabetic properties, was intended to achieve a combined hypoglycemic effect. The nanosuspension was developed using appropriate stabilizers and excipients to decrease particle size and enhance dispersion stability. The formulation's physicochemical properties, such as particle size, stability, and solubility, were assessed. Phytochemical analysis of the plant extract revealed the presence of active compounds, including flavonoids, phenolics, tannins, alkaloids, glycosides, and other secondary metabolites associated with therapeutic effects. The nanosizing technique enlarged the drug particle surface area, leading to better dissolution and increased drug absorption. The developed Glibenclamide–Bougainvillea nanosuspension exhibited enhanced solubility and is anticipated to improve oral absorption and anti-diabetic effectiveness over the standard formulation. D-pinitol's presence may aid in better glucose control via insulin-sensitizing and insulin-mimetic mechanisms.
Balaji M, Keerthika J, Krishnan K, Narmathavalli R, Abirami M, Solubility Enhancement of Glibenclamide – Bougainvillea Nanosuspension for Anti-Diabetic Activity, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 4, 1410-1418 https://doi.org/10.5281/zenodo.19479801
10.5281/zenodo.19479801